Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A-FERİN
- Development stage
- Unknown
- Lead developer
- Bilim Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A-FERİN is a multi-ingredient combination pharmaceutical product developed and marketed by Bilim Pharmaceuticals, primarily indicated for the symptomatic relief of the common cold, influenza, and other upper respiratory tract infections. The standard formulation (typically provided as capsules) contains paracetamol, which acts as an analgesic and antipyretic to reduce pain and fever; chlorpheniramine maleate, a first-generation antihistamine that alleviates symptoms such as runny nose, sneezing, and watery eyes; and codeine phosphate, an opioid derivative that serves as an antitussive to suppress cough. Bilim Pharmaceuticals also offers several variants under the A-FERİN brand, including A-FERİN Forte (which lacks codeine), A-FERİN Sinus (which includes the decongestant pseudoephedrine), and pediatric formulations like A-FERİN Plus. It is a well-established marketed product in the Turkish pharmaceutical sector.
- Brand names
- A-FERİNA-FERİN ForteA-FERİN SinusA-FERİN PlusA-FERİN Hot
- Other names
- paracetamol + chlorpheniramine maleate + codeine phosphate
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)MOR (Mu opioid receptor)
Beyond the preview
Go deeper on A-FERİN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on A-FERİN.